Showing results (1781-1790 of 5,046) with videos related to
Sort By:
Pageof 505
The Biochemical Journal|March 1, 1986
Binding of heparin to human platelet factor 4S W Cowan, E N Bakshi, K J Machin, et al.American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 24, 2024
Best practices for PGY1 letters of intent: Recommendations from a modified Delphi processAlex N Isaacs, Ma Emmanuelle Domingo, Monica L Miller, et al.Journal of Clinical Epidemiology|February 2, 2024
Using the GRADE evidence to decision framework to reach recommendations together with ethnic minority community organizations: the example of COVID-19 vaccine uptake in the United KingdomShaun Treweek, Miriam Brazzelli, Annette Crosse, et al.Journal of the American Pharmacists Association : Japha|January 12, 2024
Impact of an HIV pre-exposure prophylaxis dashboard on veteran PrEP enrollmentMary Kate Kerbler, Carrie Isaacs, Courtney Eatmon, et al.ACS Synthetic Biology|March 6, 2025
Synthetic Genetic Elements Enable Rapid Characterization of Inorganic Carbon Uptake Systems in Cupriavidus necator H16Akira K Nakamura, Emily M Fulk, Christopher W Johnson, et al.Journal of Manipulative and Physiological Therapeutics|September 9, 2011
Clinical tests for screening and diagnosis of cervical spine myelopathy: a systematic reviewChad E Cook, Mark Wilhelm, Amy E Cook, et al.The Prostate|April 26, 2006
Germline ATBF1 mutations and prostate cancer riskJunyan Xu, Jurga Sauvageot, Charles M Ewing, et al.The Prostate|May 27, 1999
No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancerE P Wilkens, D Freije, J Xu, et al.The Prostate|March 9, 2005
Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant diseaseBao-Li Chang, Sarah D Isaacs, Kathy E Wiley, et al.The Prostate|July 21, 2004
Mutational analysis of PINX1 in hereditary prostate cancerGregory A Hawkins, Bao-Li Chang, S Lilly Zheng, et al.Pageof 505